← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phelix Therapeutics, Llc
Philadelphia, PA
$5,497,839
Total funding
4
Grants
Funding over time
peak $2M · FY2015–18$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$5,497,839 · 4
By mechanism
R44$4,382,085 · 1
R01$691,707 · 1
R43$424,047 · 2
Investigators at Phelix Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS$1,475,511
R44 · FY2015 · AI
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS$1,465,763
R44 · FY2016 · AI
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS$1,440,811
R44 · FY2017 · AI
A host protein network necessary for parasite cytolysis$359,453
R01 · FY2016 · AI
A host protein network necessary for parasite cytolysis$332,254
R01 · FY2015 · AI
Cathepsin B Inhibitors as Therapeutics for Ebola Infection$222,382
R43 · FY2015 · AI
Calpain Therapeutics to Inhibit Myofibroblast Generation in Fibrosis$201,665
R43 · FY2018 · HL